Skip to main content
. 2022 Nov 15;6(12):e807. doi: 10.1097/HS9.0000000000000807

Figure 1.

Figure 1.

(A) Overall survival and (B) progression-free survival of all patients. (C) Overall survival and (D) progression-free survival stratified according to the chemotherapy type (G-CHOP and G-Bendamustine). CHOP = CVP + doxorubicine.